ATLAS / Macro Radar / Reporting / ABVC

ABVC BIOPHARMA, INC. (ABVC) reporting calendar

ABVC BIOPHARMA, INC. files periodic reports with the SEC as ABVC on Nasdaq. Atlas tracks 69 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
8 Jul 2026 – 20 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
18 May 2026
Reports on record
69

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ABVC market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202618 May 202648 days0001213900-26-058104
10-K31 Dec 20253 Mar 202662 days0001213900-26-023063
10-Q30 Sep 20253 Nov 202534 days0001213900-25-104811
10-Q30 Jun 202513 Aug 202544 days0001213900-25-075644
10-Q31 Mar 202530 Apr 202530 days0001213900-25-037676
10-K31 Dec 202415 Apr 2025105 days0001213900-25-032118
10-Q30 Sep 202414 Nov 202445 days0001213900-24-097840
10-Q30 Jun 202414 Aug 202445 days0001213900-24-068907
10-Q31 Mar 202417 May 202447 days0001213900-24-044731
10-K31 Dec 202313 Mar 202473 days0001213900-24-022235
10-Q30 Sep 202315 Nov 202346 days0001213900-23-087270
10-Q30 Jun 202314 Aug 202345 days0001213900-23-067113
10-Q31 Mar 202315 May 202345 days0001213900-23-039733
10-K31 Dec 202231 Mar 202390 days0001213900-23-025554
10-Q30 Sep 202214 Nov 202245 days0001213900-22-072317
10-Q30 Jun 202215 Aug 202246 days0001213900-22-048113
10-Q31 Mar 202216 May 202246 days0001213900-22-027157
10-K31 Dec 202131 Mar 202290 days0001213900-22-016726
10-Q30 Sep 202115 Nov 202146 days0001213900-21-059317
10-Q30 Jun 202112 Aug 202143 days0001213900-21-041730
10-Q31 Mar 202110 May 202140 days0001213900-21-025389
10-K31 Dec 202016 Mar 202175 days0001213900-21-015729
10-Q30 Sep 202017 Nov 202048 days0001213900-20-037598
10-Q30 Jun 202014 Aug 202045 days0001213900-20-022086
10-Q31 Mar 202029 Jun 202090 days0001213900-20-016186
10-K31 Dec 201915 May 2020136 days0001213900-20-012685
10-Q30 Sep 201918 Nov 201949 days0001213900-19-023848
10-Q30 Jun 20199 Aug 201940 days0001213900-19-015088
10-Q31 Mar 201928 May 201958 days0001213900-19-009633
10-K31 Dec 201815 Apr 2019105 days0001213900-19-006364
10-Q30 Sep 201814 Nov 201845 days0001213900-18-015707
10-Q30 Jun 201820 Aug 201851 days0001213900-18-011469
10-Q31 Mar 201815 May 201845 days0001213900-18-006355
10-K30 Sep 201716 Jan 2018108 days0001213900-18-000537
10-Q30 Jun 201721 Aug 201752 days0001213900-17-009012
10-Q31 Mar 201722 May 201752 days0001213900-17-005654
10-Q31 Dec 201621 Feb 201752 days0001213900-17-001662
10-K30 Sep 201612 Jan 2017104 days0001213900-17-000304
10-Q30 Jun 201615 Aug 201646 days0001615774-16-006781
10-Q31 Mar 201616 May 201646 days0001615774-16-005453

Source: SEC EDGAR company submissions for CIK 0001173313. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.